SEC Form 4Coverage since May 29, 2026
$CMMB insider trading
Over the last 12 months, Chemomab Therapeutics insiders reported 2 buys totaling $20K and no sales across SEC Form 4 filings.
- Bought · 12m
- $20K 2 events
- Sold · 12m
- — 0 events
- Events · 12m
- 2 Form 4 filings, grouped
- Insiders · 12m
- 1 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $CMMB · 12Mvia TradingView
Top insiders · 12m
Mor George AdiChief Executive Officer2× · $20K
All insider trades
2 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| May 29, 2026 | Mor George AdiChief Executive Officer · O·D | ▲ Buy | 4,926 | $2.08 | $10K | +3.7% | — |
| May 29, 2026 | Mor George AdiChief Executive Officer · O·D | ▲ Buy | 4,878 | $2.05 | $10K | +3.8% | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $CMMB feed.